A convenient microbiological assay employing cell-free extracts for the rapid characterization of Gram-negative carbapenemase producers

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 2, 2008, Pages 336-344

  Marchiaro, Patricia ^a   Ballerini, Viviana ^b   Spalding, Tamara ^a   Cera, Gabriela ^a   Mussi, María A ^a   Morán Barrio, Jorgelina ^a   Vila, Alejandro J ^a   Viale, Alejandro M ^a   Limansky, Adriana S ^a  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b Hospital I Carrasco   (Argentina)

Author keywords

lactamase detection; Bacterial disruption; Carbapenem resistance

Indexed keywords

BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFTAZIDIME; CEPHALOSPORIN; CLAVULANIC ACID; EDETIC ACID; IMIPENEM; MEROPENEM; SILICON DIOXIDE;

ACINETOBACTER BAUMANNII; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITROBACTER FREUNDII; ENZYME SPECIFICITY; GRAM NEGATIVE BACTERIUM; HYDROLYSIS; INFECTION CONTROL; INFECTION PREVENTION; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STENOTROPHOMONAS MALTOPHILIA; ULTRASOUND;

BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; BACTERIOLYSIS; BETA-LACTAMASES; BETA-LACTAMS; CLAVULANIC ACID; COMPLEX MIXTURES; EDETIC ACID; ENZYME INHIBITORS; GRAM-NEGATIVE BACTERIA; MICROSPHERES; SILICON DIOXIDE; SUBSTRATE SPECIFICITY;

EID: 47249095905     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn185     Document Type: Article

References (33)

1. Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in perill Curr Opin Microbiol 2005; 8: 518-24.
2. Babic M, Hujer AM, Bonomo RA. What's new in antibiotic resistance? Focus on β-lactamases. Drug Resist Updates 2006; 9: 142-56.
3. Queenan AM, Bush K. Carbapenemases: The versatile β-lactamases. Clin Microbiol Rev 2007; 20: 440-58.
4. Walsh TR, Toleman MA, Poirel L et al. Metallo-β-lactamases: The quiet before the storm? Clin Microbiol Rev 2005; 18: 306-25.
5. Crowder MW, Spencer J, Vila AJ. Metallo-β-lactamases: Novel weaponry for antibiotic resistance in bacteria. Acc Chem Res 2006; 39 721-8.
6. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002; 8: 321-31.
7. Cornaglia G, Akova M, Amicosante G et al. on behalf of the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS). Metallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: Open issues. Int J Antimicrob Agents 2007; 29: 380-8.
8. Rasmussen WJ, Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother 2006; 57: 373-83.
9. Chu YW, Cheung TK, Ngan JY et al. EDTA susceptibility leading to false detection of metallo-β-lactamase in Pseudomonas aeruginosa by Etest and an imipenem-EDTA disk method. Int J Antimicrob Agents 2005; 26: 340-1.
10. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum β-lactamases in Pseudomonas aeruginosa: Novel developments and clinical impacts. Antimicrob Agents Chemother 2003; 47: 2385-92.
11. Marchiaro P, Mussi MA, Ballerini V et al. Sensitive EDTA-based microbiological assays for the detection of metallo-β-lactamases in non-fermentative Gram-negative bacteria. J Clin Microbiol 2005; 43: 5648-52.
12. Paton R, Miles RS, Hood J et al. ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993; 2: 81-8.
13. Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests: Approved Standard M2-A9. CLSI, Wayne, PA, USA, 2006.
14. Vedel G. Simple method to determine β-lactam resistance phenotypes in Pseudomonas aeruginosa using the disc agar diffusion test. J Antimicrob Chemother 2005; 56: 657-64.
15. Kohler T, Michea-Hamzehpour M, Epp SF et al. Carbapenem activities against Pseudomonas aeruginosa: Respective contributions of OprD and efflux systems. Antimicrob Agents Chemother 1999; 43: 424-7.
16. Mussi MA, Limansky A, Viale A. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii natural insertional inactivation of a gene encoding a member of a novel family of β-barrel outer membrane proteins. Antimicrob Agents Chemother 2005; 49: 1432-40.
17. Gilligan PH, Whittier S. Pseudomonas and Burkholderia. In: Murray PR, Baron EJ, Ptaller MA et al., eds. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology, 1999; 517-25.
18. Pasteran F, Rapoport M, Petroni A et al. Emergence of PER-2 and VEB-1a in Acinetobacter baumannii strains in the Americas. Antimicrob Agents Chemother 2006; 50: 3222-4.
19. Woodford N, Tierno P, Young K et al. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 2004; 48: 4793-9.
20. Poirel L, Weldhagen GF, Naas T et al. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob Agents Chemother 2001; 45: 2598-603.
21. Wommer S, Rival S, Heinz U et al. Substrate-activated zinc binding of metallo-β-lactamases: Physiological importance of mononuclear enzymes. J Biol Chem 2002; 277: 24142-7.
22. Lee K, Lim YS, Yong D et al. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003; 41: 4623-9.
23. Livermore DM. β-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8: 557-84.
24. Héritier C, Poirel L, Lambert T et al. Contribution of acquired carbapenem-hydrolyzing oxacillinases to carbapenem resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 2005; 49: 3198-202.
25. Lister PD, Gardner VM, Sanders CC. Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. Antimicrob Agents Chemother 1999; 43: 882-9.
26. IMP-16 and a fused form of aminoglycoside-resistant gene aac(6′)-30/aac(6′ -lb': Report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 2004; 48: 4693-702.
27. Yano H, Kuga A, Okamoto R et al. Plasmid-encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001; 45: 1343-8.
28. Brown S, Amyes S. OXA β-lactamases in Acinetobacter: The story so far. J Antimicrob Chemother 2006; 57: 1-3.
29. VIM family in a GES-1 extended-spectrum -β-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Antimicrob Agents Chemother 2005; 49: 474-5.
30. Poirel L, Naas T, Nicolas D et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000; 44: 891-7.
31. IMP-7. Antimicrob Agents Chemother 2002; 46: 255-8.
32. Toleman MA, Simm AM, Murphy TA et al. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: Report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 2002; 50: 673-9.
33. Moran-Barrio J, Gonzalez JM, Lisa MN et al. The metallo-β-lactamase GOB is a mono-Zn(II) enzyme with a novel active site. J Biol Chem 2007; 282: 18286-93.